Paratek Pharmaceuticals

www.paratekpharma.com
1000 First Ave, Suite 200
King of Prussia, PA 19406

Company Info

Phone
(617) 807-6600

Year Established
1996

Ticker
PRTK

Exchange
NASDAQ

Contacts

Evan Loh, M.D.
CEO

Randy Brenner
CDO & CRO

Jonathan Light
Deputy General Counsel

Adam Woodrow
President & CCO

Company Description

Paratek, formerly Transcept Pharma and Novacea, is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use.